157 related articles for article (PubMed ID: 29168426)
1. Interleukin-18 and testosterone levels in men with metabolic syndrome.
Angelova P; Kamenov Z; Tsakova A; El-Darawish Y; Okamura H
Aging Male; 2018 Jun; 21(2):130-137. PubMed ID: 29168426
[TBL] [Abstract][Full Text] [Related]
2. IL-1 Antagonism in Men With Metabolic Syndrome and Low Testosterone: A Randomized Clinical Trial.
Ebrahimi F; Urwyler SA; Straumann S; Doerpfeld S; Bernasconi L; Neyer P; Schuetz P; Mueller B; Donath MY; Christ-Crain M
J Clin Endocrinol Metab; 2018 Sep; 103(9):3466-3476. PubMed ID: 29939279
[TBL] [Abstract][Full Text] [Related]
3. The Comparison of Predictive Value Among Chemerin, IL-18 and Hormonal Parameters in Assessing the Risk of Metabolic Syndrome in Men.
Jarecki P; Herman WA; Losy J; Lacka K
Am J Mens Health; 2021; 15(4):15579883211034984. PubMed ID: 34330167
[TBL] [Abstract][Full Text] [Related]
4. Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone.
Antonio L; Wu FC; O'Neill TW; Pye SR; Ahern TB; Laurent MR; Huhtaniemi IT; Lean ME; Keevil BG; Rastrelli G; Forti G; Bartfai G; Casanueva FF; Kula K; Punab M; Giwercman A; Claessens F; Decallonne B; Vanderschueren D;
J Clin Endocrinol Metab; 2016 Jul; 101(7):2647-57. PubMed ID: 26909800
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between androgens concentrations (testosterone and dehydroepiandrosterone sulfate) and metabolic syndrome in non-obese elderly men].
Rabijewski M; Papierska L; Kozakowski J; Zgliczyński W
Endokrynol Pol; 2007; 58(6):496-504. PubMed ID: 18205106
[TBL] [Abstract][Full Text] [Related]
6. Relative androgen deficiency in relation to obesity and metabolic status in older men.
Chen RY; Wittert GA; Andrews GR
Diabetes Obes Metab; 2006 Jul; 8(4):429-35. PubMed ID: 16776750
[TBL] [Abstract][Full Text] [Related]
7. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
[TBL] [Abstract][Full Text] [Related]
8. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age.
Hart RJ; Doherty DA; Mori TA; Adams LA; Huang RC; Minaee N; Handelsman DJ; McLachlan R; Norman RJ; Dickinson JE; Olynyk JK; Beilin LJ
Hum Reprod; 2019 Mar; 34(3):389-402. PubMed ID: 30576537
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between testosterone deficiency and metabolic syndrome in obese men].
Tylińska M; Broncel M
Pol Merkur Lekarski; 2013 Jan; 34(199):24-8. PubMed ID: 23488280
[TBL] [Abstract][Full Text] [Related]
10. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
11. MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
Lapauw B; Kaufman JM
Eur J Endocrinol; 2020 Dec; 183(6):R167-R183. PubMed ID: 33105105
[TBL] [Abstract][Full Text] [Related]
12. The associations between iL-18 serum levels and the prevalence of metabolic syndrome in Polish men over the age of 40 according to other selected inflammatory indices and androgens: comparison of NCEP with IDF criteria.
Herman WA; Lącka K; Kaufman E; Wójcicka M; Kramer L; Losy J
Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):423-30. PubMed ID: 21264805
[TBL] [Abstract][Full Text] [Related]
13. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
14. Relationship between insulin and hypogonadism in men with metabolic syndrome.
Caldas AD; Porto AL; Motta LD; Casulari LA
Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):1005-11. PubMed ID: 20126854
[TBL] [Abstract][Full Text] [Related]
15. Serum free testosterone and metabolic syndrome in Japanese men.
Katabami T; Kato H; Asahina T; Hinohara S; Shin T; Kawata T; Ohta A; Iwamoto T; Tanaka Y
Endocr J; 2010; 57(6):533-9. PubMed ID: 20371984
[TBL] [Abstract][Full Text] [Related]
16. Strong association between serum levels of leptin and testosterone in men.
Behre HM; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 1997 Aug; 47(2):237-40. PubMed ID: 9302400
[TBL] [Abstract][Full Text] [Related]
17. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia.
Park SG; Yeo JK; Cho DY; Park MG
Aging Male; 2018 Mar; 21(1):55-59. PubMed ID: 28414251
[TBL] [Abstract][Full Text] [Related]
18. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
Permpongkosol S; Tantirangsee N; Ratana-olarn K
J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets.
Pastuszak AW; Mittakanti H; Liu JS; Gomez L; Lipshultz LI; Khera M
J Androl; 2012; 33(5):927-37. PubMed ID: 22403285
[TBL] [Abstract][Full Text] [Related]
20. The rs5934505 single nucleotide polymorphism (SNP) is associated with low testosterone and late-onset hypogonadism, but the rs10822184 SNP is associated with overweight and obesity in a Chinese Han population: a case-control study.
Chen YP; Nie LL; Li HG; Liu TH; Fang F; Zhao K; Yang RF; Ma XL; Kong XB; Zhang HP; Guan HT; Xia W; Hong WX; Duan S; Zeng XC; Shang XJ; Zhou YZ; Gu YQ; Wu WX; Xiong CL
Andrology; 2016 Jan; 4(1):68-74. PubMed ID: 26602056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
